Apixaban is an oral anticoagulant used to reduce stroke risk in atrial fibrillation and to treat and prevent venous thromboembolism. It lowers the chance of clot formation but can cause side effects that clinicians and patients should recognise. This article summarises the most common reactions, how often and how severe they tend to be, safety considerations, and practical steps for recognising and managing complications — including when to seek medical care.
Common Side Effects
Apixaban may cause side effects, some of which need prompt evaluation. The most commonly reported reactions include:
Bleeding: signs such as unusual bruising, prolonged bleeding from cuts, nosebleeds, or bleeding gums.
Gastrointestinal effects: nausea, vomiting, or abdominal pain.
Fatigue: persistent or unusual tiredness and weakness.
Recognising these signs supports timely care. If you need a reliable source for prescriptions or medications, Drug Mart is an online pharmacy platform that supplies medications and health products to consumers.
Which Symptoms Indicate Typical Apixaban Side Effects?
Typical signs include unexpected bruising, prolonged bleeding, and gastrointestinal discomfort. Keep an eye on these symptoms and report any noticeable changes to your prescriber promptly.
How Does Apixaban Affect Bleeding Risks?
Apixaban selectively inhibits Factor Xa in the clotting cascade, which lowers the risk of thrombus formation but increases bleeding risk. Patients with other medical conditions or those taking medicines that affect haemostasis should be counselled and monitored closely.
Frequency and Severity
The rate and seriousness of side effects vary. Many patients tolerate apixaban without major problems; a smaller proportion experience complications that require medical attention. While the absolute risk of major bleeding is relatively low, it remains a key factor when making treatment decisions. Regular review and monitoring help pick up adverse events early and guide dose or therapy changes.
An analysis of FDA adverse event reports provides comparative data on haemorrhage risk between apixaban and other anticoagulants.
Apixaban Hemorrhage Risk: FDA Database Analysis From January 1, 2014 to December 31, 2019, the total number of reports of hemorrhage related to rivaroxaban was 53,085, and the numbers of apixaban and dabigatran were 13,151 and 14,100 respectively. The overall ROR (95% CI) of hemorrhagic events reporting for rivaroxaban versus dabigatran and apixaban versus dabigatran were 1.58 (1.54–1.62) and 0.47 (0.46–0.48) respectively. The RORs (95% CI) for apixaban versus dabigatran in gastrointestinal system, nervous system, renal and urinary system, skin and subcutaneous tissue, and eye system were 0.28 (0.27–0.29), 0.69 (0.66–0.73), 0.31 (0.29–0.34), 0.98 (0.86–1.12), and 1.18 (1.00–1.39), respectively. Evaluation of rivaroxaban-, apixaban-and dabigatran-associated hemorrhagic events using the FDA-Adverse event reporting system (FAERS) database, J Zhou, 2021
Safety Information
Contraindications include active clinically significant bleeding and severe renal impairment. Pregnant or breastfeeding people should consult their prescriber before starting apixaban, as safety data are limited and individual assessment is required.
Management Strategies
Care typically follows several evidence-informed approaches:
Monitoring: regular clinical review and laboratory checks to guide dosing and detect complications early.
Emergency protocols: ensure patients and carers know how to recognise major bleeding and when to seek immediate care.
Lifestyle adjustments: reduce activities with a high risk of trauma to lower the chance of bleeding.
Follow established protocols for bleeding management and peri-procedural care, and use supportive measures as indicated.
Apixaban Management Guide for Bleeding & Procedures This multi-disciplinary consensus statement has been written to serve as a guide for healthcare practitioners prescribing apixaban in Australia, with a focus on acute and emergency management. The predictable pharmacokinetics and minimal drug interactions of apixaban should allow for safe anticoagulation in the majority of patients, including temporary interruption for elective procedures. In the absence of published data, patients actively bleeding on apixaban should receive standard supportive treatment. Practical management of patients on apixaban: a consensus guide, C Ward, 2013
How Long Do Apixaban Side Effects Typically Last?
Duration varies. Mild reactions, such as short-lived gastrointestinal discomfort, often resolve within a few days. Serious events — particularly bleeding — may persist until treated and require immediate medical attention.
How Can Patients Manage and Minimize Apixaban Side Effects Safely?
Stick to the prescribed dosing, keep open communication with your healthcare team, and report any new or unexpected symptoms promptly. Healthy habits like a balanced diet, regular appropriate activity, and staying well hydrated support overall health and may lower the risk of complications.
What Strategies Help Control Bleeding Risks?
To reduce bleeding risk while taking apixaban, patients should:
Avoid NSAIDs: drugs like ibuprofen and aspirin increase bleeding risk.
Stay hydrated: keeping well hydrated supports general health.
Know bleeding signs: learn what constitutes an emergency and act quickly if they occur.
Which Lifestyle Precautions Should Be Taken While Using Apixaban?
Practical precautions include:
Avoid high-risk activities: minimise participation in activities with increased trauma risk.
Regular check-ups: attend scheduled appointments to spot adverse effects and adjust treatment as needed.
Medication review: review all prescription, OTC, and complementary medicines with your clinician to prevent harmful interactions.
What Are Important Drug Interactions and Safety Precautions with Apixaban?
Key interactions to watch for include:
Medication | Interaction | Effect |
NSAIDs | Increased bleeding risk | Higher chance of gastrointestinal bleeding |
Antidepressants | Increased bleeding risk | May enhance anticoagulant effects |
Antibiotics | Altered effectiveness | Some antibiotics can affect apixaban metabolism |
Recognising these interactions is essential for safe prescribing and use. Always tell your healthcare provider about all prescription medicines, over-the-counter drugs, and supplements you take.
Which Medications Commonly Interact with Apixaban?
Warfarin: combining with warfarin increases bleeding risk.
Rifampin: may reduce apixaban effectiveness by lowering its levels.
Clarithromycin: can raise apixaban levels and increase bleeding risk.
Consult your prescribing clinician before starting any new medication to avoid significant interactions.
It's also important to consider medication duration.
For example, coordinating steroid therapy — and following appropriate taper schedules when needed — can help manage steroid-related side effects.
Patients should understand measures to reduce bleeding risk (avoid NSAIDs, stay hydrated) and remain alert for drug interactions. Use established guidance on prednisone taper dose schedules when coordinating concurrent therapies.
Frequently Asked Questions
What should I do if I experience severe side effects while taking apixaban?
If you have severe effects — such as major bleeding, persistent severe abdominal pain, or extensive bruising — seek immediate medical care. Contact your prescriber or go to the nearest emergency department. Do not stop apixaban without clinical advice, as stopping suddenly may raise the risk of clotting. Maintain clear communication with your healthcare team.
Can I take over-the-counter medications while on apixaban?
Be cautious with OTC medicines. Many — particularly NSAIDs (ibuprofen, aspirin) — increase bleeding risk. Check with a healthcare provider before starting any new medication, supplement, or herbal product.
How does apixaban compare to other anticoagulants in terms of side effects?
Some evidence suggests apixaban has a lower incidence of certain adverse events compared with alternatives (for example, warfarin), including a reduced risk of some types of gastrointestinal bleeding in certain studies. Treatment choice should be individualised based on each patient’s benefits and risks.
Are there specific foods I should avoid while taking apixaban?
There are no strict dietary restrictions for apixaban. Unlike vitamin K antagonists, apixaban is less affected by vitamin K intake. Avoid excessive alcohol because it can increase bleeding risk. For personalised advice, speak with your healthcare provider.
What lifestyle changes can help manage apixaban side effects?
Helpful measures include regular appropriate physical activity, a balanced whole-food diet, adequate hydration, and avoiding activities that greatly increase risk of injury. Regular follow-up allows monitoring and timely treatment adjustments.
How can I recognize signs of serious bleeding while on apixaban?
Watch for unexplained or excessive bruising, visible blood in urine or stool, prolonged bleeding from minor wounds, or severe, persistent headaches. Any of these signs warrants immediate medical evaluation. Education on warning signs helps ensure a rapid response and safer therapy.
CIPA-Certified Canadian Pharmacies Provide Safe, Effective Prescription Drugs https://drugmart.com/ is a CIPA-member Canadian prescription referral service with hundreds of medications at incredible savings. We source from reputable pharmacies located in the United Kingdom, New Zealand, Australia and Canada. We offer non-prescription Canada drugs and pet medications, too!
Rest assured, even though you may receive your medication from a country other than Canada, because your order is placed through https://drugmart.com - which is a CIPA sanctioned seller - it's just as safe as if it were shipped directly from our Canadian pharmacy.
If you need expert advice, https://drugmart.com can connect you with a team of licensed pharmacists to address your concerns. Our customer service team will help with any questions you may have. You can also check out our list of FAQs to get answers to the most-asked questions we receive. Find your prescription, create an account and start saving on your meds from https://drugmart.com today!
Sources
Singer, A., Abraham, N., Ganti, L., Peacock, W., Dark, J., Ishaq, H., … & Neuenschwander, J. (2024). Evaluation and treatment of gastrointestinal bleeding in patients taking anticoagulants presenting to the emergency department. International Journal of Emergency Medicine, 17(1). https://link.springer.com/article/10.1186/s12245-024-00649-7
Tarn, D., Shih, K., Tseng, C., Thomas, A., & Schwartz, J. (2023). Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban. Jacc Advances, 2(1), 100175. https://www.jacc.org/doi/10.1016/j.jacadv.2022.100175
Brod, C., Groth, N., Rudeck, M., Artang, R., Rioux, M., & Benziger, C. (2023). Oral anticoagulation use in non-valvular atrial fibrillation patients in rural setting. American Journal of Medicine Open, 9, 100026. https://www.sciencedirect.com/science/article/pii/S2667036422000218?via%3Dihub
Related Articles
Apixaban dosing for atrial fibrillation — practical guidance on dosing and safety
Apixaban is an oral anticoagulant used to lower stroke risk in people with atrial fibrillation (AF). This guide lays out clear, evidence‑based dosing advice —...
CIPA: How Online Canadian Pharmacies Save You Money
The Canadian International Pharmacy Association (CIPA) was formed in 2002. Their job is to work with regulators, pharmacists, physicians, consumer special interest groups, government members and...
Understanding Apixaban's Maximum Daily Dose: How to Use This Anticoagulant Safely and Effectively
Apixaban is an oral anticoagulant used to prevent thromboembolic events in conditions such as atrial fibrillation and deep vein thrombosis (DVT). Knowing...
